At least nine hospitals or health systems have stopped providing gender-affirming hormones and puberty blockers to young trans people since the start of the year, in the wake of federal rules proposed in December that would withhold Medicare and Medicaid funding from clinics that continue pediatric care for transgender people.
A STAT analysis of news reports shows that more than 40 hospitals nationwide have paused or ceased to offer some type of gender-affirming care to young people since President Trump launched his first strike at the field one week into his second administration with an executive order that sought to use federal power to end such treatment for minors. Several clinics have cited increased federal pressure, including recent referrals for investigation by the Department of Health and Human Service’s Office of Inspector General.
